Oncology

Gastroenteropancreatic Neuroendocrine Tumors

Advertisment

Conference Reporter in GEP-NETs to Cover Key Topics Being Presented at the 2024 NANETS Multidisciplinary NET Medical Symposium

conference reporter by Jennifer R. Eads, MD; Diane Reidy-Lagunes, MD
Overview

Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. Conference Reporter will feature community-selected experts and topics in GEP-NETs presented at the 2024 NANETS Multidisciplinary NET Medical Symposium.

 

VIEW THE TOPICS

  • GEP-NETs: New Frontiers, Novel Strategies, and Ongoing Trials
  • Genotype-Phenotype Correlations in Neuroendocrine Tumors
  • Optimizing Dose/Duration of Kinase Inhibitors and Other Systemic Therapies
  • Updates on Alpha-Particle-Emitting Somatostatin Analogues

 

This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the North American Neuroendocrine Tumor Society.

Jennifer R. Eads, MD

Professor of Medicine
Physician Lead, GI Clinical Research
Director, National Clinical Trials Network
Director, Penn Neuroendocrine Tumor Program
Division of Hematology and Oncology
University of Pennsylvania, Abramson Cancer Center
Perelman Center for Advanced Medicine
Philadelphia, PA

Diane Reidy-Lagunes, MD

Creator and Host, Cancer Straight Talk Podcast
Vice Chair of Oncology Operations, Regional Care Network
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, NY

Advertisment